Well-tolerated Spirulina extract inhibits influenza virus replication and reduces virus-induced mortality - PubMed

Influenza is one of the most common human respiratory diseases, and represents a serious public health concern. However, the high mutability of influenza viruses has hampered vaccine development, and resistant strains to existing anti-viral drugs have also emerged. Novel anti-influenza therapies are …分類：pmid:27067133, PMC4828654, doi:10.1038/srep24253, Research Support, Non-U.S. Gov't, Yi-Hsiang Chen, Gi-Kung Chang, Shin-Ru Shih, Animals, Antiviral Agents / administration & dosage, Antiviral Agents / isolation & purification*, Antiviral Agents / pharmacology*, Antiviral Agents / toxicity, Cell Survival / drug effects, Dogs, Madin Darby Canine Kidney Cells, Mice, Orthomyxoviridae / drug effects*, Orthomyxoviridae Infections / drug therapy, Orthomyxoviridae Infections / virology, Spirulina / chemistry*, Survival Analysis, Treatment Outcome, Viral Plaque Assay, Virus Replication / drug effects*, PubMed Abstract, NIH, NLM, NCBI, National Institutes of Health, National Center for Biotechnology Information, National Library of Medicine, MEDLINE...